Residency · Syracuse, NY
Sponsored by SUNY Upstate Medical University
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
The New England journal of medicine · 2023 · 1,032 citations · Ayman Samkari
Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.
Pediatrics · 2022 · 435 citations · Jon Watchko
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
The Lancet. Oncology · 2022 · 688 citations · Ayman Samkari
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2024 · 288 citations · Ayman Samkari
Effective interventions to address maternal and child malnutrition: an update of the evidence.
The Lancet. Child & adolescent health · 2021 · 346 citations · Aamer Imdad
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
Gastroenterology · 2024 · 195 citations ·
Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal.
The New England journal of medicine · 2023 · 119 citations · Julie Riccio
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.
The Lancet. Neurology · 2021 · 399 citations · Susan Iannaccone